Market Standards Trend Report
Trends in UK Equity Capital Markets in 2025
Our contributors
Background and approach
This report provides an insight into UK ECM activity in 2025 and what we expect to see in 2026.
Lexis+® UK Corporate and Market Standards have conducted research to examine trends in respect of UK IPO and secondary offer activity in 2025. We reviewed IPOs and secondary offers on the Main Market and AIM which completed in 2025 and looked at transactions which completed in 2021, 2022, 2023 and 2024 for comparative purposes.
Our IPO data excludes introductions and transfers between markets, save where otherwise indicated. Market capitalisation has been calculated based on the closing price on the day of admission as quoted by the London Stock Exchange plc. Companies listing GDRs have been excluded from the market capitalisation data.
Our secondary offer data looks at commercial companies undertaking placings, open offers and rights issues raising at least £10m for the company.
Gross proceeds refers to gross proceeds raised by the company and does not include amounts raised by selling shareholders, save where otherwise indicated.
Deal values have been rounded to the nearest million where expressed in millions and rounded to the nearest hundred million where expressed in billions. The percentages in this report have been rounded up or down and accordingly may not in aggregate add up to 100%.
Executive summary
2025 marked a tentative improvement in UK equity capital markets, with activity picking up particularly in the second half of the year and a small number of large transactions returning to the market. While sentiment showed signs of stabilising and we saw some activity in January 2026, the first quarter of 2026 is ending against a more uncertain backdrop with the ongoing conflict in the Middle East and disruption to oil and gas markets, resulting in some significant activity in the Oil & Gas sector but a challenging market overall.
A key theme for 2025 was the continued momentum behind regulatory reform aimed at reinforcing London’s position as a leading venue for listing and capital raising. Building on the 2024/2025 overhaul of the UK listing regime, the new public offers and admissions to trading regime came into force in January 2026. The changes introduce a more flexible approach including revised prospectus threshold requirements which aim to make it quicker, easier and cheaper for companies to undertake further fundraisings.
As this report highlights, 2025 was a year of progress across the UK’s capital markets. We saw a pick-up in IPO activity across AIM and the Main Market and significant further progress was made to progress the reform agenda, in particular with the development of PISCES, the FCA’s approval of our Private Securities Market and with the future development of AIM which remains central to supporting young, dynamic and innovative companies from across the world to enable them to grow and scale. We are positioning AIM for its next stage of growth through the targeted changes to the rules introduced last year and ongoing work with stakeholders to revitalise equity investment across the UK ecosystem.
IPOs
IPO activity increased in 2025, with 23 IPOs across the Main Market and AIM, up from 17 in 2024 although volumes remained subdued by historical standards.
Main Market
Main Market IPO volumes rose modestly to nine IPOs, compared with seven in 2024. Aggregate market capitalisation of companies completing an IPO increased significantly, driven by a small number of larger transactions, most notably the dual listing of Fermi Inc., the largest IPO of the year by value (£14.5bn). Gross proceeds raised also rebounded from 2024 levels.
As in recent years, Main Market listings were significantly boosted by companies joining by way of introduction or transfer from AIM. 2025 saw a notable number of sizeable introductions, including International Paper which listed with an opening market capitalisation of over £22bn. There was a marked increase in AIM companies transferring to the Main Market with seven in 2025, reflecting the impact of the 2024 listing reforms and the continued attractiveness of the Main Market for more established businesses, particularly where a business qualifies for the FTSE 250 or other indices.
2025 saw the first tentative signs of public equity markets re-opening after a dry-period from 2021. A broad range of sectors were represented and there was optimism that provided their businesses demonstrated ongoing good performance in their post-IPO reporting cycles, confidence in UK equity markets and IPO's would steadily return. 2025 saw a continuance of listed companies being taken over and leaving the market, which ought to have been an additional catalyst for re-igniting the UK IPO market. The year also saw investors increasingly looking to retain companies on the market, rather than seeing them being taken private by private equity, such as happened with Primary Health Properties' successful cash and share offer for Assura in competition with an all-cash private equity offer. This willingness to support existing listed companies was also demonstrated by the support seen for secondary issues through the year.
UK equity capital markets showed signs of a meaningful rebound in 2025, with a modest increase in IPO activity increasing over the previous year and larger, high-profile listings buoying overall deal value despite volumes remaining below historical highs. Notable successes included the Shawbrook Group, Princes Group and Beauty Tech Group IPOs in the second half of 2025. We are optimistic that this momentum will carry over into 2026, yet uncertainty persists to date with the ongoing conflict in the Middle East and related energy market disruptions.
The consequence of a subdued IPO market is not merely inconvenience for investment bankers and advisers; it has real implications for individual investors. The most compelling growth businesses are increasingly remaining private for longer, or choosing to remain private entirely, meaning that the gains from high-growth companies are accruing almost exclusively to institutional investors in the private markets: the very pension funds that are simultaneously underinvesting in public equities. Retail investors, by contrast, find themselves locked out and only able to invest in mature companies where significant capital gains are less likely.
The narrative around IPOs needs to change. With the right regulatory environment, the right capital base and a clearer articulation of the benefits of public ownership, there is no reason why the IPO market cannot find its way back to relevance. The structural reforms underway provide a foundation; the task now is to build on them.
AIM
AIM recorded 14 IPOs in 2025, up from 10 in 2024, representing the highest level since 2021. Aggregate market capitalisation and total proceeds raised both increased, as did average deal size.
The largest AIM IPO by both value and funds raised was MHA plc, which with a market capitalisation of £275m was the highest-valued AIM IPO since 2021.
Industry sector
On the Main Market, Investment remained the most active sector by IPO volume, with three IPOs raising around 30% of all funds raised in Main Market IPOs. The Food and Beverages sector also performed well with Princes Group’s IPO raising £400m.
On AIM, Professional Services was the highest-grossing IPO sector with accountancy firm, MHA plc, raising nearly 50% of total AIM IPO proceeds for the year. The Mining, Metals and Extraction, Healthcare, Pharmaceuticals and Biotechnology and Media sectors were all represented in AIM IPOs in 2025.
Fermi’s record-breaking float was one of the biggest by market capitalisation that we have seen on the LSE in the past ten years. Texas-based Fermi chose to list in the UK to enhance its international profile and appeal to investors in the Middle East and Far East. The dual listing boosted confidence in the London market and provided traction for the later listings of Princes and Shawbrook. The global data center market is expected to grow significantly over the next five years, largely driven by AI demand and AI-linked energy infrastructure needs.
We have experienced an increasing interest among larger AIM listed companies in moving to the Main Market and our team assisted Gamma Communications plc to move to the Main Market last summer.
Typical reasons for the move include the following:
1. Greater Prestige & Market Credibility
The Main Market is viewed as the LSE’s premier listing venue, offering higher prestige and signalling corporate maturity and stability to investors. This enhanced standing can improve market confidence in the company.
2. Access to a Larger, More Diverse Investor Base
Many institutional investors and tracker funds are restricted from investing in AIM stocks. A Main Market listing opens the door to a significantly broader pool of investors, driving higher demand for the shares.
3. Potential Inclusion in FTSE Indices
Only Main Market companies qualify for the flagship FTSE indices (FTSE 100, FTSE 250, etc.). Index inclusion can materially increase liquidity due to automatic buying by index‑tracking funds.
4. Improved Liquidity & Trading Volumes
The Main Market offers deeper liquidity and materially higher average trading volumes, supporting better price discovery and potentially reducing share price volatility.
5. Enhanced Analyst Coverage & Visibility
Companies on the Main Market typically benefit from broader analyst research, improved information flow, and increased business press coverage—all of which boost profile and investor engagement.
6. Alignment with Company Growth & Maturity
A move often reflects that a business has reached a scale and level of sophistication where Main Market governance standards and investor expectations are a better fit. It can be a natural next step in the company’s lifecycle.
7. Recent Regulatory Reforms Have Reduced Barriers
The recent FCA reforms have simplified the Main Market listing structure, eased shareholder approval requirements, and streamlined eligibility—making the transition more accessible and appealing than before.
The mining and natural resources industry has now featured prominently in AIM IPOs in the past 4 years. Global copper demand is surging, driven by clean energy technologies, data centers and AI infrastructure and electric vehicles. Record-high prices of gold are encouraging mining companies to increase output. Mining companies continue to use the equity markets to fund exploration efforts and mine development, despite difficult market conditions. We see this trend enduring, largely due to energy transition demands.
IPO activity levels over the course of 2025 remained suppressed albeit we have seen a slight uptick in companies coming to market. Potential issuers across the UK and the wider global markets continue to navigate challenging market conditions which have been in existence for the preceding two/three years. However, the London markets remain stable, robust and well-equipped to withstand difficult circumstances and there have indeed been a number of success stories to bolster investor confidence.
AIM continued to attract a stable flow of high-growth companies such as accountancy and advisory firm MHA. It is notable that MHA’s £275m valuation came at a time when US reciprocal tariffs were announced causing turbulence in the global markets, which demonstrates a certain domestic robustness this side of the Atlantic. The IPO of MHA was unique in the sense that many professional services firms have favoured private equity investment rather than going down the public route. AIM’s regulatory framework should afford MHA more flexibility to execute its M&A strategy.
Secondary offers
Secondary fundraising activity was more mixed in 2025. Overall deals volumes declined, 42 transactions within our scope compared with 50 in 2024. Total funds raised fell compared with 2024 which had been significantly boosted by the £7bn National Grid rights issue.
Main Market
On the Main Market, volumes were broadly stable but aggregate proceeds were lower than in 2024. Fundraising was concentrated in a small number of larger transactions including SSE, Eutelsat Communications and Pennon Group.
AIM
AIM saw a strong year for secondary fundraising, with total proceeds increasing significantly despite fewer transactions. The £1.16bn placing and open offer by Rosebank Industries was, at the time, the largest equity fundraise ever undertaken on AIM. The company surpassed this in March 2026 with a capital raise of £1.9bn and announced its intention to move to the Main Market.
Industry sector
On the Main Market, Utilities was the highest-grossing sector for secondary fundraisings in 2025, with SSE and Pennon together accounting for over half of total proceeds. Telecommunications also featured prominently, with Eutelsat Communications’ capital raising making it the second highest sector by value.
On AIM, the fundraising by Rosebank Industries meant that Industrials was the highest grossing sector. Mining, Metals and Extraction remained a core AIM fundraising sector, and Energy also recorded substantial activity. This continues to demonstrate AIM’s important role as a market for growth and capital-intensive businesses, particularly in the natural resources space.
Rosebank’s colossal fundraises on AIM showcase the strength and efficiency of the public markets in acting as a conduit for funding strategic acquisitions. At a time when market conditions remained dampened, the track record of Rosebank’s management team appealed to major institutional investors.
Fundraising structure
Non-pre-emptive institutional placings remained the dominant structure for secondary fundraisings in 2025. A number of these transactions also included a retail offer through platforms such as RetailBook, BookBuild and WRAP.
Rights issues continued to play an important role in Main Market capital raises, although they accounted for a smaller proportion of overall proceeds than in 2024.
The momentum behind retail participation continues to build which has been facilitated by the use of technology and recent prospectus rules reform. Listed companies are no longer effectively capped at less than €8mil and changes to the ‘6-day rule’ when a prospectus must be publicly available to 3 working days should mean that issuers no longer have incentives to exclude retail investors from capital raises.
The wider economic environment with high gold prices and political focus on securing supplies of defence and battery minerals has seen a renewed interest in the mining sector generally. AIM and the Main Market should both benefit from this renewed interest.
Legal and regulatory developments
- the new public offers and admissions to trading regime under the Public Offers and Admissions to Trading Regulations 2024 and the FCA’s PRM: Admission to Trading on a Regulated Market sourcebook taking effect on 19 January 2026, increasing flexibility for secondary issuances for AIM and Main Market listed companies and facilitating greater participation by retail.
Recent reform to the UK Prospectus regime has increased the threshold for triggering the requirement for a prospectus for further issuances from 20% to 75% of existing share capital (for non CEIFs). This will enable listed companies to implement and execute capital raisings more efficiently and at reduced costs. It will be interesting to see how market practice evolves over time in terms of voluntary prospectus publications, particularly in respect of fundraisings that lean towards the full threshold or have an overseas element.
- FCA changes to the UK Listing Rules also taking effect on 19 January 2026 removing the further issuance listing application process with the FCA, meaning that once a class of securities is listed, further securities of that class are automatically listed on the Official List on issue and can be admitted to trading upon application to the LSE.
The historic further issuance listing application process added costs and regulatory burden for issuers, with inefficiencies and delays for transactions. The FCA noted that its move towards the new approach neither harmed investors nor negatively impacted their investment decision-making.
- the introduction of SDRT UK listing relief, announced in the Autumn Budget 2025, exempting certain transfers of shares in newly listed companies from SDRT for a three-year period
By introducing the new ‘listing relief’, it is clear that UK Government policy has attached significance to bolstering the success of London as a listing destination.
- the London Stock Exchange’s continued work on AIM reform following its discussion paper Shaping the Future of AIM with market participants noting a more flexible approach from AIM.
Towards the end of 2025, we saw a series of immediate changes to the AIM Rules relating to dual class share structures and related party treatment of director remuneration. These changes together with other proposed measures (for example, increasing the substantial transaction disclosure threshold and recalibrating the Nomad role) will keep AIM a dynamic and attractive market for growth companies.
- the PISCES regulatory framework coming into effect in June 2025, establishing a new regulated private market model for intermittent secondary trading in private company shares, with the LSE approved in August 2025 as the first operator of a PISCES platform
The LSE has recently welcomed the first user to launch a transaction on the Private Securities Market under the FCA’s PISCES framework. In addition, JP Jenkins announced the first PISCES trade by board games firm Qplay. It will be interesting to see what appetite companies and investors will have regarding utilisation of PISCES.
- progress towards the digitisation of share ownership following the Digitisation Taskforce’s final report in July 2025
It makes sense for the UK to work proactively to take the necessary steps to implement digitisation across the market. This should remove some friction points in the day-to-day administration of listed companies such as cumbersome, expensive and inefficient modes of shareholder communication (e.g the distribution of printed materials including notices of general meeting and of annual reports).
Against the challenging backdrop, the regulatory reform agenda does provide some genuine grounds for optimism. The launch of PISCES, the publication of the AIM Rules Feedback Statement and the introduction of the new Prospectus Regime all represent meaningful steps towards a more proportionate and accessible regulatory environment for companies considering a public listing. I have personally seen the impact of the more permissive approach to acquisitions included in the AIM Rules Feedback Statement which has made certain acquisitions more viable for smaller AIM companies. AIM should be a great place for companies to implement a buy and build strategy and this is an important part of this. The relaxation in the UKLRs around acquisitions has also been welcome and you can see the benefit of this in the recent proposed acquisition by Savills PLC of Eastdil Secured, a transaction that would have been a Class 1 without the rule changes.
As well as market conditions, 2026 saw further changes in the regulatory position, with the POATRs regime coming into effect, further simplifying the listed company regulatory environment after the Listing Rules changes introduced in 2024. Granting stamp duty relief on sales of shares in newly listed companies for three years post-IPO provided a further benefit for companies looking to IPO in the UK.
Outlook for 2026
The outlook for 2026 is cautiously balanced. While 2025 indicated a gradual increase in UK ECM activity, the escalation of conflict in the Middle East introduces a renewed layer of geopolitical risk which is weighing on market confidence. Periods of heightened volatility may continue to favour well-prepared issuers with strong equity stories and flexibility on timing.
That said, the underlying direction of travel for the UK market remains positive. The significantly more permissive regulatory environment should support more efficient and repeat access to capital for listed companies, and makes London well positioned to respond quickly when conditions stabilise.
Ongoing geo-political tensions (including conflict in the Middle East and the war in Ukraine) continue to provide a challenging environment for the UK and wider global markets. Instability and uncertainty derived from global trade factors such as tariffs, shipping and the availability of natural resources may serve to impede economic growth. Recent regulatory and legislative change governing the UK markets show that London is ever-evolving, willing, and able to adapt to the needs of potential and current issuers in order to become more efficient and less costly as a listing destination whilst preserving important investor protections.
2026 marks a pivotal year for UK capital markets with the implementation of the new Public Offers and Admissions to Trading regime. Dovetailing with the landmark listing reforms introduced in 2024, the new regime represents a structural shift in the UK capital markets framework - one designed to remove frictions, reduce costs for issuers and meaningfully broaden retail investor participation. If underpinned by a more stable geopolitical and macroeconomic backdrop, taken together, the reforms have real potential to be a key driver in the sustained renewal of the UK capital markets ecosystem.
The FTSE reached an all-time high in February 2026, yet the IPO market has conspicuously failed to follow suit. On the face of it, this is something of a paradox: buoyant equity markets should, in theory, provide the ideal conditions for companies to access public capital. We hear the pipeline of IPOs is strengthening but this hasn’t yet materialised into new listings, and the question exercising minds across the market is whether the decline of the IPO as a route to market is cyclical (a function of prevailing macroeconomic conditions and a serious hangover from ultra-low interest rates) or whether it reflects something more structural (a movement to passive investing only and companies staying private for longer) and therefore more troubling in the long term.
The beginning of the year felt positive and there were signs that this was the beginning of an IPO recovery but the ongoing conflict in Iran continues to inject uncertainty into global markets, and the spectre of renewed inflationary pressure, further interest rate rises and the possibility of recession all point to another challenging year for capital markets activity. In an environment where risk appetite is suppressed and the cost of capital remains elevated, the conditions for a meaningful IPO revival are, at best, fragile. Issuers and their advisers will need to be realistic about both timing and valuation expectations if they are to successfully bring transactions to market in 2026.
Beneath the macroeconomic noise lies a deeper, structural challenge: the availability of capital for investment in public equities. The UK faces a well-documented demographic headwind, with an ageing population increasingly drawing down on pension savings rather than accumulating them. Compounding this is the persistently conservative investment approach of many UK pension funds, which continue to underweight domestic equities relative to their international peers. The result is a diminishing pool of long-term, patient capital available to support UK public markets.
The debate around mandation, requiring pension funds to allocate a proportion of their assets to UK equities, continues to gain traction, but the existence of strong vested interests means this remains politically sensitive. A more market-led solution, frequently discussed but yet to materialise at scale, is the creation of a UK equivalent of the US 401(k): a vehicle that actively encourages retail participation in equity markets and channels individual savings into productive investment. Until the UK develops a more compelling answer to the question of how to mobilise domestic capital, the structural constraints on the IPO market will persist. The fiscal constraints on further tax incentives are understood but in my view the potential benefits to the wider economy and the UK’s “jewel in the crown” financial services sector far outweigh this.
While the improved regulatory and stamp duty positions have undoubtedly improved the position for both new IPO candidates and existing listed issuers, there is only so much which can be achieved by government and regulators and ultimately the future success of the UK markets will depend on both investor appetite and sentiment. Taken together, these signs all gave indications for a stronger recovery in the public equities market coming into 2026. However, events in the first quarter in the Middle East have resulted in that optimism receding and the general view is that investors have retreated to the nervousness about equity markets and new IPOs seen in previous years. After a very slow number of years for UK equity markets, an early settlement of the conflict and a steady performance by the UK and global economy notwithstanding the conflict should see the growing optimism seen at the start of the year returning.
The UK's regulatory shake-up has begun to have a positive impact by making it faster and easier for companies to access capital. However, measures aimed at driving increased pension fund and other investment in UK equities to improve market valuations and overall liquidity remain key in improving London's global competitiveness as a listing venue.
We anticipate that fintech innovation will continue to act as a significant driver of growth in the UK equity capital markets with the potential for the recent regulatory and market reforms to attract ambitious fintech businesses to London seeking access to capital and global investors.
It is also worth noting that Nasdaq’s recently tightened admission requirements create an opportunity for AIM.
Nasdaq’s raising of listing thresholds (including stricter liquidity requirements, higher public float minimums, and tougher rules for certain jurisdictions) will inevitably make access to US public markets harder for smaller or early‑stage companies.
This, in turn, may enhance AIM’s attractiveness to US and other companies which may have otherwise been drawn to NASDAQ, as:
- a more accessible public market
- a flexible option for smaller issuers
- a less burdensome regulatory environment.
|
Main Market IPOs |
||||
|
Company name |
Country of incorporation |
Industry sector |
Gross proceeds |
Market capitalisation |
|
Mayflower Acquisition Limited |
British Virgin Islands |
Investment |
£374m |
£374m |
|
Princes Group plc |
England and Wales |
Food & beverages |
£400m |
£1,160m |
|
Shawbrook Group plc |
England and Wales |
Banking & finance |
£50m |
£1,920m |
|
Cindrigo Holdings Limited |
Guernsey |
Energy |
£2m |
£47m |
|
The Beauty Tech Group plc |
England and Wales |
Consumer products & services |
£29m |
£300m |
|
Fermi Inc. |
United States |
Property |
£507m |
£14,523m |
|
Achilles Investment Company Limited |
Guernsey |
Investment |
£54m |
£54m |
|
Puma AIM VCT plc |
England and Wales |
Investment |
£3m |
£3m |
|
Vinanz Limited (changed name to London BTC Company Ltd |
British Virgin Islands |
Financial Services |
£2m |
£42m |
|
AIM IPOs |
||||
|---|---|---|---|---|
|
Company name |
Country of incorporation |
Industry sector |
Gross proceeds (received by the company) |
Market capitalisation |
|
All Things Considered Group PLC |
England and Wales |
Media |
£9m |
£30m |
|
Pathos Communications PLC |
England and Wales |
Media |
£6m |
£20m |
|
Power Probe PLC |
England and Wales |
Electronics |
£11m |
£62m |
|
Winvia Entertainment PLC |
England and Wales |
Travel & Leisure |
£40m |
£216m |
|
Richmond Hill Resources PLC |
England and Wales |
Mining, metals & extraction |
£2m |
£8m |
|
Vulcan Two Group PLC |
England and Wales |
Investment |
£12m |
£14m |
|
Medpal AI PLC |
England and Wales |
Healthcare, pharmaceuticals & biotechnology |
£2m |
£23m |
|
First Development Resources PLC |
England and Wales |
Mining, metals & extraction |
£2m |
£7m |
|
Sundae Bar PLC |
England and Wales |
Technology |
£2m |
£41m |
|
MHA PLC |
England and Wales |
Professional services |
£98m |
£275m |
|
Quantum Base Holdings PLC |
England and Wales |
Industrials |
£5m |
£15m |
|
Wellnex Life Limited |
Australia |
Retail |
£5m |
£21m |
|
One Health Group PLC |
England and Wales |
Healthcare, pharmaceuticals & biotechnology |
£8m |
£26m |
|
RC Fornax PLC |
England and Wales |
Industrials |
£6m |
£19m |
Report written and produced by Lexis+® Corporate and Market Insights team members
Aaliyah Syed
Market Trend Analyst
Lexis+® UK Practical Guidance
Claudia Gizejewski
Solicitor
Lexis+® Corporate
Jenisa Altink-Thumbadoo
Head of Market Insights
Lexis+® UK Practical Guidance
With thanks to our valued contributors
Tom Bacon
Partner, Bryan Cave Leighton Paisner
Tom Bacon is a Partner in BCLP’s Corporate Transactions team, with a practice focused on global public markets, advising both issuers and investment banks. He has deep experience across capital markets transactions, including IPOs, secondary offerings, and ongoing advisory for listed companies on their regulatory obligations, as well as domestic and cross-border public and private M&A. Tom works across a broad range of sectors, with particular strength in Real Estate, Energy & Natural Resources, and Technology, Media & Telecommunications (TMT). His sector knowledge complements his transactional expertise, enabling him to deliver commercially grounded advice on complex deals and regulatory matters. He is closely involved in UK regulatory and corporate governance developments, regularly advising clients on the FCA’s sponsor regime, the UK Listing Rules, AIM Rules, the UK Prospectus Regulation, ESG disclosure and governance, the Market Abuse Regulation, and broader corporate governance requirements. Tom is a frequent speaker and trainer on these topics and contributes regularly to both legal and industry publications. He serves on the Consulting Editorial Boards for Lexis+ UK and Practical Law Company, where he advises on public company and capital markets matters.
Tom Coulter
Partner, Travers Smith
Tom is a partner in our Corporate M&A and ECM Group. He specialises in advising clients on public and private mergers, acquisitions and disposals, corporate joint ventures, IPOs, equity fundraisings and general corporate advice. Tom regularly advises UK and overseas quoted and private companies, institutional investors and several financial intermediaries. He is also ranked by the Legal 500 for his ECM expertise.
Nina Driver
Senior Practice Development Lawyer, Squire Patton Boggs (UK) LLP
Nina is part of the Squire Patton Boggs UK Equity Capital Markets Practice and has over 15 years of experience advising AIM-quoted and main market listed clients on a broad range of transactions including IPOs, fundraisings, takeovers and public M&A. Nina also advises clients on corporate governance matters and non-financial reporting obligations. Nina leads the team’s knowledge management and is responsible for updates of market trends, legal and regulatory developments, legal training and advisory sessions to clients.
Clive Hopewell
Partner, Bird & Bird LLP
Clive heads up the International Capital Markets Practice across the firm. His securities practice involves acting for institutions and issuers in respect of listings in London and elsewhere. He has extensive experience advising clients in a variety of sectors, with a particular emphasis on energy and utilities and technology and communications. Clive has broad experience and a significant track record in advising corporates and investment banks on equity capital markets transactions in London and internationally. He was admitted to practice as a solicitor in England and Wales in 1994 and during his 30 year career as a corporate lawyer, he has also experienced life as a regulator, having spent two years as an adviser in the equity markets group of the London Stock Exchange. In addition to his expertise in equity capital markets, Clive works on private financings and mergers & acquisitions. He also advises entrepreneurs, family offices and high net worth individuals on corporate transactions in a variety of jurisdictions. Clive is recognised in the Hall of Fame for Capital Markets in Legal 500 and also as a leading lawyer for M&A (lower mid-market deals) and for mining in Legal 500 and as a leading lawyer in Capital Markets and in mining in Chambers & Partners.
Alexander Keepin
Partner, Simmons & Simmons LLP
Alexander is a Partner in the Simmons & Simmons Public Markets Group within its UK Corporate practice and specialises in transactions involving listed issuers on both the Main Market and AIM. Alexander acts for both issuers and underwriters/ sponsors on a range of ECM transactions including equity offerings, listings and transactions on the London markets, almost exclusively on transactions involving natural resources companies. Alexander is recognised in the Hall of Fame for Mining in the Legal 500 as well as being listed as a leading partner for Equity Capital Markets: small – mid cap and Band 2 for Mining International in Chambers and Partners.
Hannah Kendrick
Partner, Squire Patton Boggs (UK) LLP
Hannah co-leads the Squire Patton Boggs UK Equity Capital Markets Practice and has a wide range of experience advising both public and private companies on mergers and acquisitions, fundraisings, takeovers, restructurings and reorganisations. She also leads the Food and Drink Sector group for EMEA. Her work varies between UK and cross border and she works closely with executives, in-house legal teams and general counsel both in the UK and globally. Hannah also leads the team focusing on the “G” of ESG and is a member of the Regional Advisory Group of the London Stock Exchange plc for the North East.
Marianna Kennedy
Senior Associate, Ashurst LLP
Marianna Kennedy is a senior associate in Ashurst’s Corporate Transactions practice in London. Marianna specialises in advising corporate clients and investment banks on a range of equity capital markets transactions. She also advises listed company clients on corporate governance and compliance matters.
Jayson Marks
Partner, Squire Patton Boggs (UK) LLP
Jayson is a corporate Partner based in the London office, specialising in capital markets transactions for corporate and investment banking clients. He has 20+ years of experience advising on IPOs, secondary fundraisings and other equity capital markets transactions on AIM and the Main Market, as well as public and private M&A, equity investments and joint ventures. Jayson advises on complex cross-border transactions across various jurisdictions and industries, including natural resources, financial services and commodities.
Brent Sanders
Partner, Travers Smith
Brent is a partner in our Corporate M&A and ECM Group. He specialises in cross-border capital markets and corporate finance transactions, providing U.S. federal securities law advice in connection with such transactions to a broad range of corporate issuers, investment funds and underwriters. He has broad international capital markets experience advising on a range of transactions internationally, including in the UK and Europe. Brent regularly advises on issues relating to the US Securities Act, US Securities Exchange Act and US Investment Company Act, as well as US tender-offer rules, US broker dealer rules and the US Investment Advisers Act.
Alasdair Steele
Partner, CMS Cameron McKenna Nabarro Olswang LLP
Alasdair Steele is a Corporate Partner and Head of Equity Capital Markets at CMS in London specialising in UK and cross-border corporate finance, including IPOs and secondary equity issues, public and private M&A, and strategic investments as well as regularly advising on consortia and corporate joint venture arrangements. He regularly advises quoted companies and financial intermediaries on the UKLA Listing Rules and Disclosure Rules, the Prospectus Rules, the AIM Rules, the Takeover Code and general company law.
Marcus Stuttard
Head of UK Primary Markets & AIM, London Stock Exchange plc
Marcus Stuttard is Head of AIM and has responsibility for Primary Markets in the UK across both AIM and the Main Market. He is responsible for the management and development of AIM, London Stock Exchange’s international growth market for small and medium sized enterprises. Marcus has a particular focus on boosting access to finance for ambitious growth companies. He is a regular speaker on growth and business funding issues and sits on a number of industry and policy advisory bodies including the ScaleUp Institute’s Access to Finance and Growth Capital Committee and the IoD’s Centre for Corporate Governance Advisory Board. He has played a leading role in key capital market developments such as the launch of the High Growth Segment and policy changes such as making AIM shares eligible for inclusion in ISAs and the abolition of stamp duty on the trading of shares admitted to Recognised Growth Markets such as AIM.
Harry Thimont
Partner, Ashurst LLP
Harry is a partner in Ashurst's Corporate Transactions practice in London. He advises corporate clients and investment banks on a range of M&A and capital markets transactions, as well as providing governance and Board-level advice to the firm's listed company clients. Harry has been recognised by MergerLinks as a rising star among lawyers most active on UK listed company transactions and is ranked as an up-and-coming partner in Chambers UK.
